Customer Engagement Lead, Key Accounts and Contracts at Moderna

Basel, Basel-Stadt, Switzerland

Moderna Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, PharmaceuticalsIndustries

Requirements

  • Strategic and customer-focused mindset
  • Strong local market knowledge in Switzerland
  • Cross-functional collaboration skills
  • Ownership mindset ("We behave like owners")
  • Digitization mindset ("We digitize everywhere possible using the power of code")

Responsibilities

  • Own and lead customer engagement activities for all key accounts and wholesalers in Switzerland
  • Define and execute tailored engagement strategies based on deep understanding of customer needs and Moderna’s portfolio
  • Implement investment, communications, and activation strategies in collaboration with cross-functional teams
  • Lead operational planning for in-field and remote customer interactions, driving adoption of Moderna’s vaccines
  • Ensure accurate and timely delivery of vaccines by coordinating with Supply Chain, Regulatory, Quality, and Access teams
  • Collaborate on vaccination campaign development, from strategic planning to field execution
  • Drive enhancements to ordering platform tools in partnership with providers to improve customer experience
  • Serve as the point of contact for risk mitigation and contract negotiation across all commercial channels
  • Develop long-term relationships with key national and cantonal stakeholders and buying groups
  • Monitor customer performance against agreed KPIs and initiate corrective actions with internal stakeholders as needed
  • Support Moderna’s tender execution strategy in Switzerland through effective project management
  • Act as a builder of Moderna’s commercial vaccines presence in Switzerland—laying a foundation for future launches
  • Integrate customer insights, digital tools, and market analytics to continually refine engagement priorities and improve impact
  • Uphold compliance with Moderna’s policies, SOPs, and all Swiss healthcare regulations

Skills

Customer Engagement
Key Account Management
Contract Management
Commercial Strategy
Customer Service
Cross-Functional Collaboration
Market Knowledge
Wholesaler Relations
Buying Groups
Pharma Commercialization

Moderna

Develops mRNA-based medicines for health

About Moderna

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a crucial component in how cells produce proteins necessary for biological functions. Their approach involves creating a new class of medicines that utilize mRNA to instruct cells to produce specific proteins, potentially leading to significant advancements in treating diseases. Unlike traditional pharmaceuticals, which often rely on chemical compounds, Moderna's mRNA-based therapies aim to enhance the discovery, development, and manufacturing processes of medicines. The company's goal is to improve patient outcomes by harnessing the power of mRNA to create effective treatments.

Cambridge, MassachusettsHeadquarters
2010Year Founded
$5,925.5MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
5,001-10,000Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Health Savings Account/Flexible Spending Account
Unlimited Paid Time Off
Paid Vacation
Paid Sick Leave
Paid Holidays
Sabbatical Leave
Hybrid Work Options
401(k) Company Match
Parental Leave
Family Planning Benefits
Fertility Treatment Support
Adoption Assistance
Wellness Program
Mental Health Support
Phone/Internet Stipend
Home Office Stipend

Risks

Potential backlash in Australia for bypassing vaccine safety steps.
Possible removal from Nasdaq 100 Index could affect investor confidence.
Hong Kong residents' reluctance to get vaccinated may hinder market penetration.

Differentiation

Moderna is pioneering mRNA technology for new categories of medicines.
The company integrates AI to optimize mRNA design and production processes.
Moderna's mRNA platform enables rapid development of vaccines and therapeutics.

Upsides

Moderna received a $176 million contract for a bird flu vaccine.
The company is expanding mRNA applications to personalized cancer vaccines.
Moderna is establishing a domestic mRNA production facility in Australia.

Land your dream remote job 3x faster with AI